Skip to main content

Site notifications

VANCOMYCIN ALPHAPHARM 500 mg (as hydrochloride) powder for injection vial, Alphapharm Pty Ltd, CON-737

Product name
VANCOMYCIN ALPHAPHARM 500 mg (as hydrochloride) powder for injection vial
Sponsor name
Alphapharm Pty Ltd
Consent start
Consent no.
CON-737
Duration
The consent is effective for all batches of the products released from 21 January 2021 until 31 January 2023.
Standard
Paragraphs 10(5)(b) and 10(3)(a) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines
Non-compliance with standard
The products do not conform with the requirements of paragraphs 10(5)(b) and 10(3)(a) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines in that the carton labels do not include the name and quantity of each excipient in the medicine.
Import, Supply, &/or Export
Import, supply and export
Therapeutic product type
Prescription medicines